An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065)

NCT00130806 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: MK0478 (muraglitazar)
DRUG: Comparator: placebo

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]